Dr. Gillett and Nurse Practitioner James O'Hara delve into the reasons why withholding the publication of studies can be detrimental. 00:00 Intro 01:05 Undisclosed Human Study 07:07 Rapamycin and Ketamine Combination 15:50 Lifespan Impact: SIRT2 Transgenic Over-expression in Mice 18:23 Collaborative FDA Letter Addressing Obesity 21:36 Advocating for the Publication of Surprising Findings 28:32 Insights from Dr. Gillett's Surgical Experience 29:34 Conclusion Studies/References ► https://clinicaltrials.gov/study/NCT03190785#publications ► https://pubmed.ncbi.nlm.nih.gov/32092760/ ► https://onlinelibrary.wiley.com/doi/full/10.1111/acel.14027 ► https://acsess.onlinelibrary.wiley.com/doi/full/10.2134/ael2015.10.0007 ► https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.15370 For High-quality labs: ► https://gilletthealth.com/order-lab-panels/ For information on the Gillett Health clinic, lab panels, and health coaching: ► https://GillettHealth.com Follow Gillett Health for more content from James and Kyle ► https://instagram.com/gilletthealth ► https://www.tiktok.com/@gilletthealth ► https://twitter.com/gilletthealth ► https://www.facebook.com/gilletthealth Follow Kyle Gillett, MD ► https://instagram.com/kylegillettmd Follow James O’Hara, NP ► https://Instagram.com/jamesoharanp For 10% off Gorilla Mind products including SIGMA: Use code “GH10” ► https://gorillamind.com/ For discounts on high-quality supplements ►https://www.thorne.com/u/GillettHealth #podcast #study #discussion #science #gilletthealth Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy